GDS Wealth Management boosted its holdings in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 62.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 77,285 shares of the semiconductor company's stock after acquiring an additional 29,758 shares during the quarter. GDS Wealth Management's holdings in Lam Research were worth $5,619,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Smallwood Wealth Investment Management LLC acquired a new stake in Lam Research in the 1st quarter valued at approximately $26,000. West Paces Advisors Inc. acquired a new stake in Lam Research in the 4th quarter valued at approximately $27,000. Mpwm Advisory Solutions LLC acquired a new stake in Lam Research in the 4th quarter valued at approximately $27,000. Park Square Financial Group LLC acquired a new stake in Lam Research in the 4th quarter valued at approximately $31,000. Finally, Putney Financial Group LLC acquired a new stake in Lam Research in the 4th quarter valued at approximately $36,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.
Lam Research Stock Performance
Shares of NASDAQ LRCX opened at $100.33 on Wednesday. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $126.98 billion, a price-to-earnings ratio of 24.12, a PEG ratio of 1.28 and a beta of 1.65. The stock's fifty day simple moving average is $97.90 and its 200 day simple moving average is $84.22. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $108.02.
Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.21 by $0.12. The business had revenue of $5.17 billion for the quarter, compared to analysts' expectations of $4.99 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The company's quarterly revenue was up 33.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.03 EPS. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. As a group, sell-side analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several research firms recently commented on LRCX. Summit Insights cut Lam Research from a "buy" rating to a "hold" rating in a research report on Thursday, July 31st. Wall Street Zen upgraded Lam Research from a "hold" rating to a "buy" rating in a research report on Saturday, August 2nd. Erste Group Bank began coverage on Lam Research in a research report on Thursday, August 14th. They set a "buy" rating on the stock. Wells Fargo & Company set a $98.00 price target on Lam Research and gave the company an "equal weight" rating in a research report on Thursday, July 31st. Finally, Needham & Company LLC lifted their price target on Lam Research from $110.00 to $115.00 and gave the company a "buy" rating in a research report on Thursday, July 31st. Twenty analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. Based on data from MarketBeat, Lam Research currently has a consensus rating of "Moderate Buy" and an average price target of $107.09.
Check Out Our Latest Stock Analysis on LRCX
About Lam Research
(
Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.